Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.

著录项

• 来源
  《Nature medicine》 |2021年第2期|共10页
• 作者

  Jordan R Barrett; Sandra Belij-Rammerstorfer; Christina Dold; Katie J Ewer; Pedro M Folegatti; Ciaran Gilbride; Rachel Halkerston; Jennifer Hill; Daniel Jenkin; Lisa Stockdale; Marije K Verheul; Parvinder K Aley; Brian Angus; Duncan Bellamy; Eleanor Berrie; Sagida Bibi; Mustapha Bittaye; Miles W Carroll; Breeze Cavell; Elizabeth A Clutterbuck; Nick Edwards; Amy Flaxman; Michelle Fuskova; Andrew Gorringe; Bassam Hallis; Simon Kerridge; Alison M Lawrie; Aline Linder; Xinxue Liu; Meera Madhavan; Rebecca Makinson; Jack Mellors; Angela Minassian; Maria Moore; Yama Mujadidi; Emma Plested; Ian Poulton; Maheshi N Ramasamy; Hannah Robinson; Christine S Rollier; Rinn Song; Matthew D Snape; Richard Tarrant; Stephen Taylor; Kelly M Thomas; Merryn Voysey; Marion E E Watson; Daniel Wright; Alexander D Douglas; Catherine M Green; Adrian V S Hill; Teresa Lambe; Sarah Gilbert; Andrew J Pollard; Oxford COVID Vaccine Trial Group;

  展开▼
• 作者单位

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Public Health England;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Clinical BioManufacturing Facility The Jenner Institute Nuffield Department of Medicine;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Clinical BioManufacturing Facility The Jenner Institute Nuffield Department of Medicine;

  Public Health England;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Public Health England;

  Public Health England;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Public Health England;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  Clinical BioManufacturing Facility The Jenner Institute Nuffield Department of Medicine;

  Public Health England;

  Public Health England;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Clinical BioManufacturing Facility The Jenner Institute Nuffield Department of Medicine;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  The Jenner Institute Nuffield Department of Medicine University of Oxford;

  Oxford Vaccine Group Department of Paediatrics University of Oxford;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 医药、卫生;
• 关键词